PTEN and prostate carcinoma: Prostate cancer with 3p13-14 FOXP1-SHQ1 loss nonetheless shows statistically independent enrichment of PTEN loss and ERG fusion, which themselves only show co-enrichment with each other in cancers without FOXP1-SHQ1 loss.